Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Sildenafil for Hand-Foot Skin Reaction
NCT03229512Phase 1Completed
- Sponsor
- Northwestern University
- Start
- Apr 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sildenafil in Hand-foot skin reaction (HFSR), sponsored by Northwestern University. Primary endpoint: Evidence of hand-foot skin reaction at 12 weeks. Started Apr 2017; status: completed.
02
Drugs
sildenafil
03
Conditions
Hand-foot skin reaction (HFSR)
Beyond the preview
Go deeper on NCT03229512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03229512.